Iovance 生物治療公司
IT ˙ BIT ˙ US4622601007
€3.72 ↑0.28 (8.31%)
2026-06-04
分享價格
SecurityIT:1IOVA / Iovance Biotherapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership321,650 shares
Latest Disclosed Value $ 878,105
Alliancebernstein L.p. reports 24.24% increase in ownership of 1IOVA / Iovance Biotherapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 321,650 shares of Iovance Biotherapeutics, Inc. (IT:1IOVA) valued at $1,016,414 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 258,890 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 24.24% during the quarter. The current value of the position is $1,194,930 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 321,650 62,760 24.24 878 24.36 0.0002
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 258,890 0 0.00 707 25.85 0.0002
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 258,890 0 0.00 562 26.07 0.0002
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 258,890 -4,600 -1.75 445 -49.26 0.0001
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 263,490 -501,909 -65.57 877 -84.51 0.0003
2025-02-12 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 765,399 134,269 21.27 5,664 -4.44 0.0019
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 631,130 301,098 91.23 5,926 123.96 0.0020
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 330,032 14,592 4.63 2,647 -43.39 0.0009
2024-05-14 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 315,440 62,550 24.73 4,675 127.45 0.0017
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 252,890 -90,300 -26.31 2,056 31.65 0.0008
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 343,190 -528,913 -60.65 1,562 -74.57 0.0007
2023-08-15 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 872,103 -78,929 -8.30 6,140 5.66 0.0025
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 951,032 617,131 184.82 5,811 172.39 0.0025
2023-02-15 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 333,901 162,401 94.69 2,134 29.82 0.0010
2022-11-15 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 171,500 0 0.00 1,643 -13.21 0.0008
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 171,500 106,340 163.20 1,893 74.47 0.0009
2022-05-13 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 65,160 -188,547 -74.32 1,085 -77.60 0.0004
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 253,707 17,665 7.48 4,843 -16.80 0.0017
2021-11-10 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 236,042 127,366 117.20 5,821 105.83 0.0023
2021-07-30 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 108,676 -2,267,138 -95.43 2,828 -96.24 0.0011
2021-05-06 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,375,814 589,285 32.98 75,218 -9.26 0.0330
2021-02-08 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,786,529 573,719 47.30 82,895 107.62 0.0391
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,212,810 -159,819 -11.64 39,926 5.96 0.0215
2020-08-13 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,372,629 -60,763 -4.24 37,679 -12.19 0.0221
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,433,392 -438,444 -23.42 42,909 -17.18 0.0308
2020-02-18 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,871,836 80,699 4.51 51,812 58.94 0.0294
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,791,137 653,618 57.46 32,599 16.88 0.0203
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,137,519 912,419 405.34 27,892 1,202.76 0.0173
2019-05-14 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 225,100 75,000 49.97 2,141 61.22 0.0014
2019-02-13 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 150,100 4,700 3.23 1,328 -18.83 0.0010
2018-11-08 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 145,400 0 0.00 1,636 -12.09 0.0011
2018-08-13 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 145,400 -70,700 -32.72 1,861 -49.04 0.0013
2018-05-14 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 216,100 154,500 250.81 3,652 640.77 0.0026
2018-02-13 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 61,600 0 0.00 493 3.35 0.0004
2017-11-13 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 61,600 0 0.00 477 5.30 0.0004
2017-08-10 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 61,600 22,000 55.56 453 53.56 0.0004
2017-05-11 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 39,600 0 0.00 295 7.27 0.0002
2017-02-13 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 39,600 0 0.00 275 -15.64 0.0002
2016-11-10 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 39,600 0 0.00 326 1.56 0.0003
2016-08-11 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 39,600 28,400 253.57 321 463.16 0.0003
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 11,200 0 0.00 57 -33.72 0.0000
2016-02-16 2015-12-31 13F/A-1 LION BIOTECHNOLOGIES COM 53619R102 11,200 11,200 86 0.0001
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 11,200 65
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.